Edwards Lifesciences Comprehensive Income 2010-2024 | EW

Edwards Lifesciences comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
  • Edwards Lifesciences comprehensive income for the quarter ending September 30, 2024 was $-0.220B, a 13.82% decline year-over-year.
  • Edwards Lifesciences comprehensive income for 2023 was $-0.243B, a 4.75% decline from 2022.
  • Edwards Lifesciences comprehensive income for 2022 was $-0.255B, a 61.64% increase from 2021.
  • Edwards Lifesciences comprehensive income for 2021 was $-0.158B, a 2.11% decline from 2020.
Edwards Lifesciences Annual Comprehensive Income
(Millions of US $)
2023 $-243
2022 $-255
2021 $-158
2020 $-161
2019 $-156
2018 $-139
2017 $-133
2016 $-198
2015 $-183
2014 $-101
2013 $-28
2012 $-38
2011 $-38
2010 $-42
2009 $-8
Edwards Lifesciences Quarterly Comprehensive Income
(Millions of US $)
2024-06-30 $-220
2024-03-31 $-233
2023-12-31 $-243
2023-09-30 $-250
2023-06-30 $-256
2023-03-31 $-255
2022-12-31 $-255
2022-09-30 $-256
2022-06-30 $-224
2022-03-31 $-187
2021-12-31 $-158
2021-09-30 $-155
2021-06-30 $-160
2021-03-31 $-172
2020-12-31 $-161
2020-09-30 $-158
2020-06-30 $-146
2020-03-31 $-152
2019-12-31 $-156
2019-09-30 $-156
2019-06-30 $-138
2019-03-31 $-141
2018-12-31 $-139
2018-09-30 $-139
2018-06-30 $-151
2018-03-31 $-121
2017-12-31 $-133
2017-09-30 $-143
2017-06-30 $-158
2017-03-31 $-182
2016-12-31 $-198
2016-09-30 $-171
2016-06-30 $-179
2016-03-31 $-173
2015-12-31 $-183
2015-09-30 $-169
2015-06-30 $-147
2015-03-31 $-148
2014-12-31 $-101
2014-09-30 $-71
2014-06-30 $-41
2014-03-31 $-32
2013-12-31 $-28
2013-09-30 $-43
2013-06-30 $-48
2013-03-31 $-52
2012-12-31 $-38
2012-09-30 $-37
2012-06-30 $-51
2012-03-31 $-25
2011-12-31 $-38
2011-09-30 $-23
2011-06-30 $-10
2011-03-31 $-16
2010-12-31 $-42
2010-09-30 $-24
2010-06-30 $-53
2010-03-31 $-25
2009-12-31 $-8
2009-09-30 $-7
2009-06-30 $-24
2009-03-31 $-34
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $39.340B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $209.197B 25.52
Intuitive Surgical (ISRG) United States $190.823B 99.77
Alcon (ALC) Switzerland $45.517B 32.04
IQVIA Holdings (IQV) United States $39.384B 21.70
IDEXX Laboratories (IDXX) United States $35.808B 42.17
DexCom (DXCM) United States $27.463B 41.36
Waters (WAT) United States $22.607B 33.43
SONOVA HOLDING (SONVY) Switzerland $22.062B 0.00
STERIS (STE) Ireland $21.899B 25.21
Hologic (HOLX) United States $18.440B 19.46
Sysmex ADR (SSMXY) Japan $12.915B 40.50
Fresenius Medical Care AG KGaA (FMS) Germany $12.552B 12.89
Globus Medical (GMED) United States $11.102B 28.27
Penumbra (PEN) United States $9.290B 91.00
Teleflex (TFX) United States $9.197B 14.67
Masimo (MASI) United States $8.654B 41.87
Glaukos (GKOS) United States $7.887B 0.00
PROCEPT BioRobotics (PRCT) United States $5.083B 0.00
Integer Holdings (ITGR) United States $4.679B 26.52
Inari Medical (NARI) United States $3.123B 0.00
Veracyte (VCYT) United States $3.014B 90.44
TransMedics (TMDX) United States $2.991B 94.80
LivaNova (LIVN) United Kingdom $2.813B 16.24
Nihon Kohden (NHNKY) Japan $2.554B 19.40
Elekta AB (EKTAY) Sweden $2.304B 18.77
Tandem Diabetes Care (TNDM) United States $2.060B 0.00
Integra LifeSciences Holdings (IART) United States $1.964B 10.26
RxSight (RXST) United States $1.867B 0.00
Alphatec Holdings (ATEC) United States $1.375B 0.00
Artivion (AORT) United States $1.210B 80.19
Pulse Biosciences (PLSE) United States $1.155B 0.00
OPKO Health (OPK) United States $1.072B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.951B 16.16
ORTHOFIX MEDICAL INC (OFIX) United States $0.764B 0.00
IRadimed (IRMD) United States $0.727B 39.28
Pacific Biosciences Of California (PACB) United States $0.670B 0.00
SiBone (SIBN) United States $0.664B 0.00
Mesa Laboratories (MLAB) United States $0.646B 15.23
Paragon 28 (FNA) United States $0.637B 0.00
AxoGen (AXGN) United States $0.615B 0.00
OrthoPediatrics (KIDS) United States $0.605B 0.00
Treace Medical Concepts (TMCI) United States $0.516B 0.00
CVRx (CVRX) United States $0.384B 0.00
Tactile Systems Technology (TCMD) United States $0.383B 20.73
Semler Scientific (SMLR) United States $0.379B 25.43
Delcath Systems (DCTH) United States $0.318B 0.00
ClearPoint Neuro (CLPT) United States $0.315B 0.00
AngioDynamics (ANGO) United States $0.302B 0.00
Inogen (INGN) United States $0.262B 0.00
Sight Sciences (SGHT) United States $0.233B 0.00
NeuroPace (NPCE) United States $0.213B 0.00
Atossa Genetics (ATOS) United States $0.204B 0.00
Accuray (ARAY) United States $0.199B 0.00
Nevro (NVRO) United States $0.198B 0.00
Alpha Tau Medical (DRTS) Israel $0.157B 0.00
KORU Medical Systems (KRMD) United States $0.132B 0.00
908 Devices (MASS) United States $0.125B 0.00
Sensus Healthcare (SRTS) United States $0.116B 17.19
Spectral Diagnostics (EDTXF) Canada $0.114B 0.00
EDAP TMS S.A (EDAP) France $0.094B 0.00
LENSAR (LNSR) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.079B 0.00
Covalon Technologies (CVALF) Canada $0.076B 0.00
Monogram Orthopaedics (MGRM) United States $0.076B 0.00
Vicarious Surgical (RBOT) United States $0.066B 0.00
Hyperfine (HYPR) United States $0.066B 0.00
EnVVeno Medical (NVNO) United States $0.064B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
Lucid Diagnostics (LUCD) United States $0.057B 0.00
Rapid Micro Biosystems (RPID) United States $0.055B 0.00
Accelerate Diagnostics (AXDX) United States $0.048B 0.00
Envoy Medical (COCH) United States $0.042B 0.00
Biosig Technologies (BSGM) United States $0.038B 0.00
Adagio Medical Holdings (ADGM) United States $0.035B 0.00
Neuronetics (STIM) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Precision Optics (POCI) United States $0.030B 0.00
Spectral AI (MDAI) United States $0.026B 0.00
NexGel (NXGL) United States $0.022B 0.00
Baird Medical Investment Holdings (BDMD) $0.020B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.017B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
Autonomix Medical (AMIX) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
PAVmed (PAVM) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
Pixie Dust Technologies (PXDT) Japan $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00